Rapid market expansion in established healthcare systems like the UK and Germany signals growing clinical acceptance and patient access to cannabis medicine. This trend provides valuable real-world data on prescription patterns and patient outcomes in regulated medical frameworks that can inform evidence-based practice globally.
Both the UK and German medical cannabis markets experienced significant growth in 2025, with market values doubling year-over-year. This expansion reflects increased physician prescribing, improved patient access through healthcare systems, and growing clinical familiarity with cannabis therapeutics. The growth occurs within established regulatory frameworks that require medical oversight and documentation, providing structured data on clinical applications and patient responses.
“Market growth in rigorous healthcare systems like these creates the clinical data infrastructure we desperately need – real prescribing patterns, patient outcomes, and safety profiles at scale. This is how cannabis medicine matures from anecdote to evidence.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
I notice that the article body you provided appears to be incomplete HTML formatting code without the actual news content. The text cuts off mid-sentence and doesn’t contain the substantive information needed to generate meaningful FAQs.
To create accurate frequently asked questions and answers, I would need the complete article text that discusses the actual news story, findings, or developments. Could you please provide the full article content?